AMPK stimulators (Metabasis/Merck & Co)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameAMPK stimulators (Metabasis/Merck & Co)
Drug Alias NameAMP-activated protein kinase stimulators (Metabasis/Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMetabasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetabasis Therapeutics IncMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A